Search clinical trials for: daclizumab (immunosuppressive)

Total 15021 results

University of Maryland, Baltimore

Completed

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Lymphoma | Radiation Toxicity

United States
Rockefeller University
Facet Biotech

Completed

To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris

Psoriasis

United States
University Hospital, Lille
Erasme University Hospital

Completed

Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk (TAXI)

Renal Transplantation

France
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Efficacy of Islet After Kidney Transplantation

Type 1 Diabetes Mellitus

United States, Canada
Weill Medical College of Cornell University

Terminated

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Glucocorticosteroid Refractory Acute GVHD

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus in Kidney Transplant Recipients

Kidney Transplantation | Graft vs Host Disease

Norway, Sweden
Sidney Kimmel Cancer Center at Thomas Jefferson...

Withdrawn

Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

Kidney Transplantation | Plasmapheresis

United States
Astellas Pharma Inc

Completed

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX (TAST)

Liver Transplantation

Italy
Hoffmann-La Roche

Completed

A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants

Heart Transplantation

Spain
Biogen

Completed

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis (OBSERVE)

Relapsing-Remitting Multiple Sclerosis

Poland, Hungary, United States, Czech Republic
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

B-Lymphocyte Immunotherapy in Islet Transplantation

Type 1 Diabetes Mellitus

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

Graft Versus Host Disease

United States
Hoffmann-La Roche

Completed

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Kidney Transplantation

Belgium, Spain, Sweden, Germany, United States, France, Canada, United Kingdom, Australia, Poland, Norway, Mexico
Baylor Research Institute
Medical University of South Carolina; University of Alabama at Birmingham; University... and other collaborators

Completed

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

End Stage Liver Disease | Hepatitis C

United States
JHSPH Center for Clinical Trials
National Eye Institute (NEI)

Completed

Multicenter Uveitis Steroid Treatment (MUST) Trial (MUST)

Uveitis

United States, Australia, United Kingdom
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy

Non-small Cell Lung Cancer

China
University of Minnesota
Genentech, Inc.

Completed

Studies of Kidney Transplant Outcome

Post-Transplant Infections | Thymoglobulin | Transplant Recipient (Kidney) | Steroid-Free Maintenance Immunosuppression

United States
Johns Hopkins University

Completed

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Kidney Failure, Chronic

United States
Persephone Biosciences
Pharm-Olam International

Recruiting

Development and Analysis of a Stool Bank for Cancer Patients

Carcinoma, Non-Small-Cell Lung | Carcinoma, Colorectal

United States
Spanish Network for Research in Infectious Diseases
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Unknown

Immunosupressive Treatment in COVID-19 Patients (SAM-COVID)

COVID-19 Infection

Spain
Sun Yat-sen University

Recruiting

Multi-model Image of Immunosuppressive Agents in TAO

Thyroid Associated Ophthalmopathy

China
Imperial College Healthcare NHS Trust

Completed

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

Graft Rejection | End-stage Renal Failure

United Kingdom
Hoffmann-La Roche

Completed

A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation

Heart Transplantation

United States, Canada, Germany, Sweden
Hoffmann-La Roche

Completed

Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

Renal Transplantation

France
Albert Einstein Healthcare Network
Veloxis Pharmaceuticals

Active, not recruiting

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

Post Liver Transplant

United States
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation in Children

Completed

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

Liver Transplant | Kidney Transplant | Heart Transplant | EBV-Related PTLD | Small Intestine Transplant | PTLDs

United States
The Catholic University of Korea

Unknown

Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients (tolerance)

Liver Transplantation

Korea, Republic of
Rigshospitalet, Denmark

Completed

Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Liver Transplantation
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Islet Transplantation for Type 1 Diabetes

Diabetes Mellitus, Insulin-Dependent

United States, Canada, Italy, Switzerland, Germany
Klemens Budde
Charite University, Berlin, Germany; DESCARTES Working Group On Transplantation and other collaborators

Unknown

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients (REDUCE)

Immunosuppression After Renal Transplantation
University of Rome Tor Vergata

Completed

De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

Single Transplant | 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS

Italy
Chiesi Farmaceutici S.p.A.

Completed

The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

Kidney Transplant

Italy
Fujian Medical University

Unknown

ATG-F VS ATG for the Prevention of GVHD

GVHD in the Setting of Haplo-HSCT

China
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; Rho Federal... and other collaborators

Terminated

Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation

Cardiac Allograft Vasculopathy | Heart Transplant Recipients

United States
Ospedale San Raffaele
Juvenile Diabetes Research Foundation

Completed

Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation (ECIT-1)

Type 1 Diabetes

Italy, Switzerland
Womb Transplant UK
Imperial College London

Unknown

Human Clinical Trial of Uterine Transplantation in the United Kingdom

Infertility
Peking University Third Hospital

Not yet recruiting

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Cancer Therapy-related Cardiovascular Toxicity

China
ORIOL BESTARD
Department of Health, Generalitat de Catalunya

Unknown

Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients (BIOIMMUN)

Kidney Transplant Failure and Rejection

Spain
Central Hospital, Nancy, France

Active, not recruiting

Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis

Kidney Transplantation | Dialysis | Immunosuppressive Agents | HLA Sensitization

France
University of Oslo School of Pharmacy

Completed

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

Renal Transplant Recipients
Beijing 302 Hospital

Unknown

Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

Evidence of Liver Transplantation

China
Xiaoli Fan

Unknown

Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis

Hepatitis, Autoimmune

China
Peking Union Medical College Hospital

Recruiting

Telitacicept in Primary APS Patients

Anti Phospholipid Syndrome

China
Sociedad Argentina de Reumatologia

Completed

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection (SAR-COVID)

Rheumatic Diseases

Argentina
Children's Hospital of Fudan University

Recruiting

Combined Immunosuppression for Pediatric Crohn's Disease

Crohn Disease | Immunosuppression | Children, Only | Infliximab

China
Yonsei University

Not yet recruiting

Effect of Immunosuppression in IgA Nephropathy

Biopsy-proven IgA Nephropathy

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients (EVERKYSTE)

Autosomal Dominant Polycystic Kidney Disease

France

Search clinical trials for: daclizumab (immunosuppressive)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations